-
Exceptional Outcomes in a Phase Ib Study Combining PARP and MEK Inhibition, With or Without Anti-PD-L1, for BRCA-Wildtype Platinum-Sensitive Recurrent Ovarian Cancer
Study
EGAS00001007496
-
Highly complex single-cell mixture of 5 individuals of high cell number
Dataset
EGAD50000000480
-
TOTHER3 dataset
Dataset
EGAD50000000562
-
scRNA/TCR-seq of CD8+ T cells from a melanoma patient
Dataset
EGAD50000000854
-
Total RNA sequencing of fibroblasts from an control individual
Dataset
EGAD50000000922
-
WGS of Newly Diagnosed and Refractory/Relapsed Multiple Myeloma
Dataset
EGAD50000001177
-
MDACC Lymphoma & Myeloma WGS of Tumor and Non-tumor Cells in Multiple Myeloma
Dac
EGAC50000000282
-
Results of RNA sequencing from all patients/samples
Dataset
EGAD50000000017
-
Processed Total RNA Counts for the RNA Profiling from Indian HFrEF Cohort Dataset
Dataset
EGAD50000001193
-
Processed miRNA Counts for the miRNA Profiling from Indian HFrEF Cohort Dataset
Dataset
EGAD50000001195